Audit in process? Call the number on your audit letter to get options.
Site Logo
Health care professionals website
DPL Global Search
DPL Utility Nav
DPL Main Nav
DPL Global Search
DPL Utility Nav
Breadcrumbs
SubHero Banner
RxNews®
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Movantik® (naloxegol) – New warning
August 22, 2016 – The FDA approved a new update to the Warnings and Precautions section of the Movantik (naloxegol) drug label, regarding severe abdominal pain and/or diarrhea.
